Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year.
Kaiser Permanente has dropped its $525 million contract with Owens & Minor for medical-surgical supply distribution, marking the second time that the supplier has reported a major contract loss in less than a year.
How the oncology care center approach can help address obesity-related chronic disease.
A House committee says the Food and Drug Administration's regulation of drug compounding is veering from the intent of the law passed in 2013 in the wake of a national meningitis outbreak tied to unsanitary practices at a compounding pharmacy.
The proposed rules clarify the amount of drugs that providers can compound without a prescription, set requirements for health system compounding pharmacies and clarify how large-scale compounding sites known as “outsourcing facilities” may be set up.
The New York-based pharma giant announced Thursday that it will immediately begin providing enough Daklinza to treat 10,000 patients over the next two years. Bristol-Myers will provide drugs for patients in Ethiopia, Myanmar, Nigeria, Rwanda and Vietnam.
A former Pfizer CEO now sits on ViewRay's board. Henry “Hank” McKinnell Jr. sees a lot of potential in the Oakwood Village, Ohio, company's MRI-guided radiation therapy system, according to a news release issued by ViewRay.
Moving to bundled payment represents a sweeping change for most healthcare systems. On one hand, bundled payment poses financial risk. On the other, it offers an opportunity to crack one of the toughest nuts in healthcare cost—the world of physician preference items.
There's no one-size-fits-all approach, but here are a few tips to get you started
The price of insulin, a drug that's been around for nearly a century, has been steadily rising, surpassing the cost of similar treatments and becoming an increasingly unaffordable necessity for the roughly 6 million Americans with diabetes. And in this case, innovation may be to blame.
Giant medical supplier Medline is buying a Canadian company in a deal that will help one of the Chicago area's biggest companies bulk up even more.
Omron Healthcare, a $7 billion heart health technology manufacturer and distributor, named Ranndy Kellogg president and CEO, giving him responsibility for operations in the U.S. and Canada.